← back to search

Fuxing Liu

Nantong University · CN
🔎 Find collaborators in Molecular Biology · Cancer Research →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Molecular Biology · Cancer Research
Research interest
Research focused on Cancer and Pancreatic cancer, with related work in Oncology, Cancer research, Immunohistochemistry. Notable publications include 'Increased expression of plakophilin 3 is associated with poor prognosis in ovarian cancer', 'Diagnosis, clinicopathological characteristics and prognosis of pulmonary mucinous adenocarcinoma', and 'A demonstration based on multi-omics transcriptome sequencing data revealed disulfidptosis heterogeneity within the tumor microenvironment of esophageal squamous cell carcinoma'.
h-index
citations
147
works
8
NIH funding
primary concept
email

Recent publications

The power and the promise of CAR-mediated cell immunotherapy for clinical application in pancreatic cancer
Journal of Advanced Research 2024cited by 17position: middledoi
KLK10/LIPH/PARD6B/SLC52A3 are promising molecular biomarkers for the prognosis of pancreatic cancer through a ceRNA network
Heliyon 2024cited by 5position: middledoi
A demonstration based on multi-omics transcriptome sequencing data revealed disulfidptosis heterogeneity within the tumor microenvironment of esophageal squamous cell carcinoma
Discover Oncology 2023cited by 19position: firstdoi
Galectin-1 promotes gastric cancer peritoneal metastasis through peritoneal fibrosis
BMC Cancer 2023cited by 14position: middledoi
Protocadherin 8 (PCDH8) Inhibits Proliferation, Migration, Invasion, and Angiogenesis in Esophageal Squamous Cell Carcinoma
Medical Science Monitor 2020cited by 14position: middledoi
Increased expression of plakophilin 3 is associated with poor prognosis in ovarian cancer
Medicine 2019cited by 35position: middledoi
Diagnosis, clinicopathological characteristics and prognosis of pulmonary mucinous adenocarcinoma
Oncology Letters 2017cited by 27position: middledoi
Angiopoietin-like protein 3 is an indicator of prognosis in esophageal cancer patients.
PubMed 2015cited by 16position: middle

Grants

No grants ingested yet.

Frequent collaborators

Hong Yu · First Affiliated Hospital of Xi'an Jiaotong University5 papers (2015–2024)Jingjing Bao · Nantong University4 papers (2015–2020)Haihui Sheng · Nantong University2 papers (2019–2023)Xiaowei Zhu · Sun Yat-sen University2 papers (2015–2020)Xin-Yun Liu · Nantong University2 papers (2024–2024)Da Fu · Fudan University2 papers (2024–2024)Yu‐Shui Ma · Renji Hospital2 papers (2024–2024)Weiguang Jia · Nantong University2 papers (2015–2017)Donglan Yuan · Nanjing University of Chinese Medicine2 papers (2019–2023)Junxing Huang · Jiangsu University2 papers (2019–2020)Fei Sun · Sun Yat-sen University Cancer Center1 papers (2017–2017)Lin Jiang · Jiangxi University of Traditional Chinese Medicine1 papers (2024–2024)Huiling Zhou · Nantong University1 papers (2020–2020)Hua Qian · Nanchang University1 papers (2019–2019)Yiwei Zhou · Fudan University1 papers (2024–2024)Jibin Liu · Nantong University1 papers (2024–2024)Chun Yang · Jiangnan University1 papers (2024–2024)Yizhi Cao · China Pharmaceutical University1 papers (2024–2024)Huilan Liu · University of Science and Technology of China1 papers (2023–2023)Kaijin Lu · Nantong University1 papers (2017–2017)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Molecular Biology · Cancer Research →